Gait and Energy Expenditure in Children With Lower Limb Amputation (MAPEDE)

NCT ID: NCT07076602

Last Updated: 2025-07-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

48 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-01

Study Completion Date

2028-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In lower limb amputation, prosthetic gait has been shown to be particularly energy-intensive. While energy expenditure has been the focus of many studies in adult amputees, this area of research is less developed for paediatric amputees. However, the increase in energy expenditure has implications for the physical, gait, and balance abilities of amputees of all ages. Combined with physical deconditioning, it exposes the patient to a greater risk of a sedentary lifestyle and weight gain, which is detrimental to their prosthetic training, autonomy, and length of hospital stay. However, this increased expenditure and deconditioning is not currently the subject of systematic evaluation in routine clinical practice for this population. In contrast to adults, the gait pattern of children amputees is poorly described, and the relation between energy expenditure and gait is rarely discussed. Oxygen consumption is the most widely used outcome to assess energy expenditure in studies. The main aim of this study was to identify the kinematic gait parameters obtained by quantified gait analysis associated with oxygen consumption during a 6-minute test in children with lower-limb amputations aged 7 years or older. This study also makes it possible to evaluate with the child's physician and rehabilitators the usefulness of measuring energy expenditure to guide medical decisions and rehabilitative care. Finally, it will allow the validation of a tool for this population for measuring energy expenditure that has been presented as more easily applicable in clinical routine than the measurement of oxygen consumption, the Physiological Cost Index (PCI). The validity and reliability of the PCI will therefore be evaluated. This study will therefore facilitate the assessment and monitoring of child amputees and provide guidance for the provision of an evidence-based rehabilitation program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The selection of subjects is carried out by the doctor of the center to which the child is attached. After obtaining consent, the study will be conducted in the movement analysis laboratory of the recruiting center, over the course of one day, comprising two sessions of 2.5 hours each. This study visit is separate from routine follow-up care.

One session will include a physiotherapy assessment and the evaluation of energy expenditure (oxygen consumption and Physiological Cost Index PCI) during a of 6-minute walking test.

The other session will include the assessment of kinematic parameters during a gait analysis and again the assessment of energy expenditure during a of 6-minute walking test.

FOLLOW-UP VISIT The report of all tests carried out will be made available to the child's physician and physiotherapists. An electronic questionnaire will be sent to them three to six months following the child' inclusion, to assess the usefulness of the information provided by the energy expenditure measurement and gait analysis in their practice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amputation of Lower Extremity, All Causes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Gait and energy expenditure

Inclusion of a single day comprising two sessions of 2.5 hours each (both sessions can be interchanged) SESSION 1 : Physiotherapy assessment + Measurement of energy expenditure SESSION 2 : Measurement of kinematic parameters by gait analysis + Measurement of energy expenditure

Gait and energy expenditure

Intervention Type OTHER

SESSION 1:

Physiotherapy assessment: clinical parameters, length of limb segments, range of motion of the lower limbs, muscle strength of each lower limb joint and trunk.

Measurement of energy expenditure:

6-minute walking test with prosthesis, at a constant submaximal speed, with portable gas exchange analyzer to measure oxygen consumption and a connected device to calculate the Physiological Cost Index.

* During test: recording of heart rate at the start, each minute, at the end then 5 minutes after the end, recording of the effort perceived by the child each minute (Borg scale)
* At the end : questionnaire to assess child level of acceptability regarding the measurement of the O2 (Oxygen) consumption

SESSION 2:

Measurement of kinematic parameters by gait analysis: the child will be requested to walk with their prosthesis and shoes at spontaneous speed and at maximal gait speed.

The second measurement of energy expenditure will be conducted using the same procedure as the first.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gait and energy expenditure

SESSION 1:

Physiotherapy assessment: clinical parameters, length of limb segments, range of motion of the lower limbs, muscle strength of each lower limb joint and trunk.

Measurement of energy expenditure:

6-minute walking test with prosthesis, at a constant submaximal speed, with portable gas exchange analyzer to measure oxygen consumption and a connected device to calculate the Physiological Cost Index.

* During test: recording of heart rate at the start, each minute, at the end then 5 minutes after the end, recording of the effort perceived by the child each minute (Borg scale)
* At the end : questionnaire to assess child level of acceptability regarding the measurement of the O2 (Oxygen) consumption

SESSION 2:

Measurement of kinematic parameters by gait analysis: the child will be requested to walk with their prosthesis and shoes at spontaneous speed and at maximal gait speed.

The second measurement of energy expenditure will be conducted using the same procedure as the first.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Minor aged 7 and over
* Congenital (transverse agenesis with break in limb continuity) or acquired (any etiology) transfemoral or transtibial amputation. \[In the case of femoral agenesis, the flexion axis of the prosthetic knee must coincide with the contralateral one to optimize the analysis of the kinematic parameters of gait\].
* Definitive prosthesis in place (no restriction on choice of prosthetic components)
* Legal representatives not opposing participation in the study for the child

Exclusion Criteria

* Revision surgery on the residual limb within the last 3 months
* Progressive pathology associated with amputation (unstabilized sarcoma for example) which can strongly influence walking and/or energy expenditure
* Patient already included in an interventional research protocol that could lead to bias in the present study
Minimum Eligible Age

7 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rennes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

LAURANE MAIGNAN-GOTER

Role: PRINCIPAL_INVESTIGATOR

Centre 01 - CHU de RENNES, Hôpital Pontchaillou

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre 02 - CHU Brest, Hôpital Morvan

Brest, , France

Site Status

Centre 04 - Hospices Civils de Lyon, Hôpital Mère Enfant Groupement Hospitalier Est

Bron, , France

Site Status

Centre 03 - CHU Dijon, Hôpital Le Bocage

Dijon, , France

Site Status

Centre 01 - CHU de RENNES, Hôpital Pontchaillou

Rennes, , France

Site Status

Hôpitaux Paris Est Val-de-Marne, Hôpital Saint-Maurice

Saint-Maurice, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

LAURANE MAIGNAN-GOTER

Role: CONTACT

+33299284299

ALAIN CARO

Role: CONTACT

+33299289496

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

LAËTITIA HOUX, MD

Role: primary

+33298223152

MARIE-DORIANE MORARD, MD

Role: primary

+33679928100

ANAÏS GOUTERON, MD

Role: primary

+33380293815

LAURANE MAIGNAN-GOTER

Role: primary

+33299284299

NATHALY QUINTERO-PRIGENT, MD

Role: primary

+33143966350

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A01990-47

Identifier Type: REGISTRY

Identifier Source: secondary_id

35RC23_9872_MAPEDE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Walking Inclined Plane
NCT02988557 COMPLETED NA